Acaluxen (Acalabrutinib) 100mg

Acaluxen (Acalabrutinib) 100mg

Acaluxen 100mg contains Acalabrutinib, a targeted cancer therapy used to treat certain blood cancers including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Acalabrutinib works by inhibiting Bruton’s tyrosine kinase (BTK), which helps block cancer cell growth and survival.

Field Details
Original Brand Calquence
Generic Brand Acaluxen 100
Generic Name Acalabrutinib 100mg
Pack Size 30 Capsules
Use / Indications Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL)
Manufacturer Everest Pharmaceuticals Ltd. (Produced in Bangladesh)
Status Prescription Only Medicine

Introduction to Calquence (Acalabrutinib) 100mg 

Calquence (Acalabrutinib) 100mg is a prescription medicine used in the treatment of certain blood cancers, particularly chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). This medicine belongs to a specialized group of targeted oncology drugs that help block signals responsible for cancer cell growth.

Calquence (Acalabrutinib) 100mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Acalabrutinib, which works by inhibiting Bruton’s tyrosine kinase (BTK), a protein that plays a key role in the survival and proliferation of malignant B-cells.

In some markets, Acaluxen 100mg is available as a generic brand containing the same active ingredient Acalabrutinib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Calquence (Acalabrutinib)? 

Calquence is the brand name for Acalabrutinib, an oral medication widely used for the treatment of certain hematologic (blood-related) cancers.

Acalabrutinib belongs to a class of medicines known as Bruton’s Tyrosine Kinase (BTK) Inhibitors. These medicines help block specific signaling pathways in cancer cells that promote their survival and growth.

Generic versions such as Acaluxen 100mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action 

Acalabrutinib is classified as a targeted anticancer therapy and BTK inhibitor with strong antineoplastic properties.

How Acalabrutinib Works 

It works in several ways:

  • Inhibits Bruton’s tyrosine kinase (BTK) signaling
  • Blocks growth signals in malignant B-cells
  • Prevents cancer cell survival and proliferation

Through these mechanisms, Acalabrutinib helps slow or stop the progression of certain blood cancers.

How Calquence Works in the Body 

Certain blood cancers develop when abnormal B-cells multiply uncontrollably. Calquence works by blocking the BTK enzyme involved in signaling pathways that promote cancer cell survival.

Key Actions of Acalabrutinib 

  • Blocking BTK signaling pathways in cancer cells
  • Preventing abnormal B-cell growth and division
  • Helping reduce cancer cell survival

Some generic versions such as Acaluxen deliver the same active compound, allowing similar targeted cancer treatment when prescribed appropriately.

Medical Uses of Calquence (Acalabrutinib) 100mg 

Calquence 100mg is widely prescribed for several hematologic cancers.

Calquence for Chronic Lymphocytic Leukemia (CLL) 

Calquence is commonly used to treat patients with chronic lymphocytic leukemia, either as monotherapy or in combination with other treatments.

Potential Benefits 

  • Slows progression of leukemia
  • Targets cancer cells with precision
  • Improves treatment outcomes for patients with CLL

Generic alternatives like Acaluxen 100mg may also be used under medical supervision when Acalabrutinib therapy is recommended.

Calquence for Mantle Cell Lymphoma (MCL) 

Calquence may also be used in patients with mantle cell lymphoma, particularly in cases where the disease has relapsed or is resistant to previous therapies.

Treatment Benefits 

  • Inhibits growth of lymphoma cells
  • Helps control disease progression
  • Provides targeted therapy for B-cell malignancies

Who Can Take Acaluxen 100mg? 

Because Acalabrutinib is a potent targeted therapy, treatment should always be supervised by an experienced healthcare provider.

Eligibility Criteria 

Patients may be prescribed Calquence if they:

  • Are diagnosed with chronic lymphocytic leukemia (CLL)
  • Have mantle cell lymphoma (MCL)
  • Require targeted therapy for B-cell malignancies

Certain generic options such as Acaluxen may also be considered depending on availability and physician decision.

Who Should Avoid Calquence (Acalabrutinib) 100mg 

Calquence should NOT be used by:

  • Individuals with hypersensitivity to Acalabrutinib
  • Patients with uncontrolled bleeding disorders
  • Individuals with severe liver impairment unless monitored by a specialist

Calquence (Acalabrutinib) 100mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

  • Calquence 100mg taken twice daily
  • Capsules should be swallowed whole with water
  • Can be taken with or without food

Dosage Adjustments 

Doctors may adjust the dose depending on:

  • Liver function tests
  • Drug interactions with other medications
  • Individual treatment response

Side Effects of Calquence 100mg 

Like many targeted cancer medicines, Calquence may cause side effects.

Common Side Effects 

  • Headache
  • Fatigue
  • Muscle pain
  • Diarrhea

Serious Side Effects 

  • Increased risk of bleeding
  • Serious infections
  • Heart rhythm problems (atrial fibrillation)

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children.

Frequently Asked Questions (FAQs) 

1. What type of cancer is Calquence (Acalabrutinib) 100mg used for? 

Calquence is mainly used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).

2. Is Calquence chemotherapy? 

No. Calquence is not traditional chemotherapy. It is a targeted therapy that blocks the BTK signaling pathway involved in cancer cell survival.

3. How long do patients take Acalabrutinib? 

Many patients take Acalabrutinib continuously as long as the treatment remains effective and well tolerated.

4. Can Acaluxen 100mg be taken with food? 

Yes. Acalabrutinib capsules can generally be taken with or without food unless directed otherwise by a doctor.

5. Can pregnant women take Acaluxen 100mg? 

No. Acaluxen 100mg should not be used during pregnancy because Acalabrutinib may harm an unborn baby.

6. Is Acaluxen 100mg the same as Calquence? 

Acaluxen 100mg contains Acalabrutinib, the same active ingredient found in Calquence. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764

7. Do I need a prescription to buy Acaluxen (Acalabrutinib) 100mg? 

Yes. Acaluxen 100mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer 

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Calquence (Acalabrutinib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.

 

Let's Chat!